{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:06:24Z","timestamp":1786133184516,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK47060"],"award-info":[{"award-number":["R01 DK47060"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL114567"],"award-info":[{"award-number":["R01 HL114567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1681\/asn.2019121291","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T16:05:16Z","timestamp":1579881916000},"page":"236-238","source":"Crossref","is-referenced-by-count":4,"title":["Renal Functional Decline in Sickle Cell Disease and Trait"],"prefix":"10.1681","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-5506","authenticated-orcid":false,"given":"Karl A.","family":"Nath","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Vercellotti","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"B1-20230829","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: Renal manifestations and mechanisms","volume":"11","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B2-20230829","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/17474086.2017.1395279","article-title":"The spectrum of sickle hemoglobin-related nephropathy: From sickle cell disease to sickle trait","volume":"10","author":"Naik","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"B3-20230829","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.2009070705","article-title":"High prevalence of sickle cell trait in African Americans with ESRD","volume":"21","author":"Derebail","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B4-20230829","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/ki.2011.286","article-title":"Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans","volume":"80","author":"Hicks","year":"2011","journal-title":"Kidney Int"},{"key":"B5-20230829","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2016101086","article-title":"Sickle cell trait and the risk of ESRD in Blacks","volume":"28","author":"Naik","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230829","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1681\/ASN.2019050502","article-title":"Kidney function decline among black patients with sickle cell trait and sickle cell disease: An observational cohort study","volume":"31","author":"Olaniran","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B7-20230829","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10739680490278592","article-title":"The perfusion paradox and vascular instability in sickle cell disease","volume":"11","author":"Nath","year":"2004","journal-title":"Microcirculation"},{"issue":"Suppl 1","key":"B8-20230829","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2018.06.021","article-title":"Kidney disease among African Americans: A population perspective","volume":"72","author":"Laster","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B9-20230829","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjh.12690","article-title":"Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia","volume":"164","author":"Saraf","year":"2014","journal-title":"Br J Haematol"},{"key":"B10-20230829","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI26857","article-title":"Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice","volume":"116","author":"Belcher","year":"2006","journal-title":"J Clin Invest"},{"key":"B11-20230829","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2018-06-848705","article-title":"The current state of sickle cell trait: Implications for reproductive and genetic counseling","volume":"132","author":"Pecker","year":"2018","journal-title":"Blood"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2019121291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:29:58Z","timestamp":1786130998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2019121291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2019121291","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]}}}